Disc Medicine, Inc. Shares Outstanding (Cover Page)
Disc Medicine, Inc. (IRON) had Shares Outstanding (Cover Page) of 38.39 million shares as of 2026-07-23, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-07-30
- 2026-07-23: Entity Common Stock, Shares Outstanding 38.39M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 38.20M shares.
- 2026-02-19: Entity Common Stock, Shares Outstanding 38.16M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 37.75M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-23 | 38.39M shares 10-Q · filed 2026-07-30 |
| 2026-04-30 | 38.20M shares 10-Q · filed 2026-05-05 |
| 2026-02-19 | 38.16M shares 10-K · filed 2026-02-26 |
| 2025-10-31 | 37.75M shares 10-Q · filed 2025-11-06 |
| 2025-07-31 | 34.77M shares 10-Q · filed 2025-08-07 |
| 2025-04-30 | 34.63M shares 10-Q · filed 2025-05-07 |
| 2025-02-21 | 34.57M shares 10-K · filed 2025-02-27 |
| 2024-11-07 | 29.76M shares 10-Q · filed 2024-11-12 |
| 2024-08-05 | 29.73M shares 10-Q · filed 2024-08-08 |
| 2024-05-06 | 24.72M shares 10-Q · filed 2024-05-09 |
| 2024-02-29 | 24.68M shares 10-K · filed 2024-03-21 |
| 2023-11-07 | 24.14M shares 10-Q · filed 2023-11-09 |
| 2023-08-08 | 22.88M shares 10-Q · filed 2023-08-11 |
| 2023-05-10 | 19.80M shares 10-Q · filed 2023-05-15 |
| 2023-02-28 | 19.00M shares 10-K · filed 2023-03-31 |
| 2022-11-04 | 43.33M shares 10-Q · filed 2022-11-10 |
| 2022-08-05 | 43.24M shares 10-Q · filed 2022-08-11 |
| 2022-04-29 | 43.23M shares 10-Q · filed 2022-05-06 |
| 2022-02-28 | 43.21M shares 10-K · filed 2022-03-10 |
| 2021-11-10 | 43.11M shares 10-Q · filed 2021-11-15 |
| 2021-08-10 | 43.11M shares 10-Q · filed 2021-08-12 |
| 2021-05-11 | 43.05M shares 10-Q · filed 2021-05-13 |
| 2021-03-15 | 43.00M shares 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |